In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Restoration of Efficacy of Spinal Cord timulation After Conversion From Percutaneous to Paddle Leads

    Final Number:
    305

    Authors:
    Chen Xu M.D.; Raj Kiran Nangunoori MD; Nestor Denys Tomycz MD

    Study Design:
    Other

    Subject Category:
    Pain

    Meeting: 2016 ASSFN Biennial Meeting

    Introduction: Spinal cord stimulation (SCS) is widely used for conditions such as failed back surgery syndrome (FBSS) and complex regional pain syndrome (CRPS I and II). While percutaneous or paddle lead systems are both viable options, percutaneous lead systems have a tendency to lose efficacy due to a higher migration rate, resulting in loss of clinical efficacy.

    Methods: A retrospective chart review was conducted to identify patients who had lost efficacy from their percutaneous SCS systems and were converted to a paddle lead system, regardless of etiology.

    Results: From 2013 to 2016, 7 patients were identified with a mean age of 54.8 years (range: 32-80) who had received benefit from percutaneous lead systems and presented for evaluation with loss of efficacy. A total of 5 male and 2 female patients underwent conversion from percutaneous to paddle lead systems with a restoration and/or improvement in their symptom coverage. Diagnoses included FBSS (71.43%) and CRPS (28.57%), with a mean follow-up duration of 21 months (range: 2-36 months).

    Conclusions: Failure of percutaneous SCS stimulation should not deter using SCS as a treatment modality for patients with a recurrence of their symptoms. While patients should be evaluated on a case-by-case basis, conversion to a paddle-lead system may allow for recapture of their clinical benefit and improve quality of life.

    Patient Care: To allow recapture of patients' previous clinical benefit from SCS, improve quality of life, and not consider these patients as those who failed SCS.

    Learning Objectives: To show recapture of clinical efficacy of SCS after conversion to paddle lead system from percutaneous lead system

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy